Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth

NCT00006135 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

NIH

Sponsor class

Conditions

Herpes Simplex

Interventions

DRUG: acyclovir

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]